Quality Chemical Industries Limited (UGSE:QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
89.00
0.00 (0.00%)
At close: Jul 4, 2025
60.36%
Market Cap 325.02B
Revenue (ttm) 267.13B
Net Income (ttm) 40.65B
Shares Out 3.65B
EPS (ttm) 11.13
PE Ratio 7.99
Forward PE n/a
Dividend 13.50 (15.17%)
Ex-Dividend Date Aug 5, 2025
Volume n/a
Average Volume 191
Open n/a
Previous Close 89.00
Day's Range n/a
52-Week Range 45.27 - 89.00
Beta -0.16
RSI 100.00
Earnings Date Jun 16, 2025

About UGSE:QCIL

Quality Chemical Industries Limited, a pharmaceutical manufacturing company based in Uganda, produces treatments for HIV/AIDS, malaria, hepatitis, and other medical conditions. The company offers a range of products, including antibacterials, antihypertensives, vasodilators, antiemetics, antibiotics, and antidiabetic medications. Specifically, it provides Lamivudine/Tenofovir Disoproxil Fumarate, Dolutegravir, Efavirenz, and Zidovudine tablets for the treatment of HIV infection. Additionally, the company offers Lumartem/Lumet tablets for malari... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In 2024, UGSE:QCIL's revenue was 267.13 billion, an increase of 0.67% compared to the previous year's 265.34 billion. Earnings were 40.65 billion, an increase of 28.00%.

Financial Statements

News

There is no news available yet.